Skip to content

The outcomes following Percutaneous Endoscopic Transforaminal Lumbar Interbody Fusion (PETLIF) and Minimally Invasive Transforaminal Lumbar Interbody Fusion surgery (MIS-TLIF) for the treatment of lumbar disease: a randomized controlled trial

The outcomes following Percutaneous Endoscopic Transforaminal Lumbar Interbody Fusion (PETLIF) and Minimally Invasive Transforaminal Lumbar Interbody Fusion surgery (MIS-TLIF) for the treatment of lumbar disease: a randomized controlled trial

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
TCTR
Registry ID
TCTR20240708003
Enrollment
44
Registered
2024-07-08
Start date
2023-08-10
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients who diagnosed Degenerative Lumbar disease, causing Lumbar spondylolisthesis, lumbar discherniated, Lumbar spinal stenosis. Percutaneous Endoscopic Transforaminal Lumbar Interbody Fusion, PETLIF, Endo-TLIF, Minimally Invasive Transforaminal Lumbar Interbody Fusion surgery, MIS-TLIF, TLIF, Degenerative Lumbar disease

Interventions

Percutaneous endoscopic lumbar inter body fusion (PETLIF) is a minimally invasive spine surgical technique for spondylolisthesis and lumbar spinal canal stenosis with instability with full endoscopic
Experimental Procedure/Surgery,Experimental Procedure/Surgery
PETLIF,MIS-TLIF

Sponsors

Faculty of Medicine Ramathibodi Hospital, Mahidol University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age over 18 yr with consent to ethics 2.Patients who diagnosed Degenerative Lumbar disease, causing Lumbar spondylolisthesis, lumbar discherniated, Lumbar spinal stenosis 3.Patients who diagnosed Degenerative Lumbar disease with dynamic radiographs, computed tomography scan, magnetic resonance imaging 4.Patients were treated with fully medical and rehabilitation threrapy at least 3 months, which is clinical outcomes not improve

Exclusion criteria

Exclusion criteria: 1.Patients who had a history of prior to spine surgery 2.Patients who rejected or withdrawed from research protocol 3.Patients who had a clinical of caudal equina syndrome 4.Patients who had a history of recent spine infection or others systemic infection 5.Patients who had a history of coagulopathy or anemia

Design outcomes

Primary

MeasureTime frame
functional outcomes 12 months after end of the intervention VisualAnalogScale, Oswestry Disability Index

Secondary

MeasureTime frame
QOL, sagittal balance, fusion rate 12 months after end of the intervention Modified Macnab criteria score, plain film X ray, CT scan

Countries

Thailand

Contacts

Public ContactEkkapong Konkaew

Faculty of Medicine Ramathibodi Hospital.

ekkapong.kon@student.mahidol.ac.th0917745945

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026